Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction

Haematologica

Volumn 99, Issue 9, 2014, Pages 1465-1471

  Thanasopoulou, Angeliki ^a   Tzankov, Alexandar ^b   Schwaller, Juerg ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA; NUCLEOPORIN 98; PROTEIN NSD1; UNCLASSIFIED DRUG; FLT3 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; NUP98-NSD1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN KINASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CELL IMMORTALIZATION; CELL PROLIFERATION ASSAY; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DUPLICATION; GENE EXPRESSION; GENE FUSION; GENE MUTATION; HISTOPATHOLOGY; IMMUNOPHENOTYPING; INTERNAL TANDEM DUPLICATION; LEUKEMOGENESIS; MICROSCOPY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MUTATION; PATHOLOGY; PRIMARY CELL CULTURE; PROTEIN TERTIARY STRUCTURE; RETROVIRUS;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTATION; ONCOGENE PROTEINS, FUSION; PRIMARY CELL CULTURE; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 84907362988     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.100917     Document Type: Article

References (31)

1. Riva L, Luzi L, Pelicci PG. Genomics of acute myeloid leukemia: the next generation. Front Oncol. 2012;1;2:40.
2. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150(2):264-78.
3. Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366(12):1090-8.
4. Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100(5):1532-42.
5. Meshinchi S, Appelbaum FR. Structural and functional alterations of FLT3 in acute myeloid leukemia. Clin Cancer Res. 200;15(13):4263-9.
6. Kelly LM, Liu Q, Kutok JL, Williams IR, Boulton CL, Gilliland DG. FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. Blood. 2002;99 (1):310-8.
7. Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, et al. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci USA. 2002;99(12):8283-8.
8. Schessl C, Rawat VP, Cusan M, Deshpande A, Kohl TM, Rosten PM, et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest. 2005;115(8):2159-68.
9. Ono R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki T, et al. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leuke-mogenesis. J Clin Invest. 2005;115(4):919-29.
10. Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, Agarwal J, et al. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Leukemia. 2008;22 (1):66-77.
11. Reckzeh K, Bereshchenko O, Mead A, Rehn M, Kharazi S, Jacobsen SE, et al. Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model. Leukemia. 2012;26(7):1527-36.
12. Greenblatt S, Li L, Slape C, Nguyen B, Novak R, Duffield A, et al. Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model. Blood. 2012;119(12):2883-94.
13. Tam WF, Hähnel PS, Schüler A, Lee BH, Okabe R, Zhu N, et al. STAT5 is crucial to maintain leukemic stem cells in acute myel-ogenous leukemias induced by MOZ-TIF2. Cancer Res. 2013;73(1):373-84.
14. Grundler R, Miething C, Thiede C, Peschel C, Duyster J. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct pheno-types in a murine bone marrow transplantation model. Blood. 2005;105(12):4792-9.
15. Grundler R, Brault L, Gasser C, Bullock AN, Dechow T, Woetzel S, et al. Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration. J Exp Med. 2009;206(9):1957-70.
16. Chu SH, Heiser D, Li L, Kaplan I, Collector M, Huso D, et al. FLT3-ITD knockin impairs hematopoietic stem cell quiescence/home-ostasis, leading to myeloproliferative neoplasm. Cell Stem Cell. 2012 7;11(3):346-58.
17. Jaju RJ, Fidler C, Haas OA, Strickson AJ, Watkins F, Clark K, et al. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood. 2001;98 (4):1264-7.
18. Brown J, Jawad M, Twigg SR, Saracoglu K, Sauerbrey A, Thomas AE, et al. A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay. Blood. 2002;99(7):2526-31.
19. Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Pratcorona M, Abbas S, Kuipers JE, et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood. 2011;118(13): 3645-56.
20. Thol F, Kolking B, Hollink IH, Damm F, van den Heuvel-Eibrink MM, Michel Zwaan C, et al. Analysis of NUP98/NSD1 translocations in adult AML and MDS patients. Leukemia. 201;27(3):750-4.
21. Fasan A, Haferlach C, Alpermann T, Kern W, Haferlach T, Schnittger S. A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene. Leukemia. 2013;27(1):245-8.
22. Pigazzi M, Manara E, Bisio V, Aveic S, Masetti R, Menna G, et al. Screening of novel genetic aberrations in paediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group. Blood. 2012;120 (18):3860-2.
23. Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogene-sis. Nat Cell Biol. 2007;9(7):804-12.
24. Liu T, Jankovic D, Brault L, Ehret S, Baty F, Stavropoulou V, Rossi V, Biondi A, Schwaller J. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia. Leukemia. 2010;24(3): 601-12.
25. Demant P. Cancer susceptibility in the mouse: genetics, biology and implications for human cancer Nat Rev Genet. 2003; 4(9):721-34.
26. Williams RT, Sherr CJ. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias. Cold Spring Harbor Laboratory Press. 2008;73:461-7.
27. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 1997;16(14):4226-37.
28. So CW, Karsunky H, Wong P, Weissman IL, Cleary ML. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood. 2004;103(8):3192-9.
29. Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J. 2001;20(3): 350-61.
30. Gough SM, Slape CI, Aplan PD. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood. 2011;118(24):6247-57.
31. Akiki S, Dyer SA, Grimwade D, Ivey A, Abou-Zeid N, Borrow J, Jeffries S, Caddick J, et al. NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prog-nostically relevant subgroup of paediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR. Genes Chromosomes Cancer. 2001; 52(11): 1053-64.